The Importance of Diagnostics
The Importance of Diagnostics
Randox was established in 1982 to address the need for accurate and readily available diagnostic tests to improve patient diagnosis. Around 70% of all medical decisions are based on laboratory results, and so, not surprisingly, we believe that earlier, more accurate and more accessible diagnostics are the key to improving global health and saving lives.
And yet, until now, in spite of their contribution to clinical decision making, and the important role they play in patient outcomes, diagnostic tests have only accounted for 2% of the UK’s national health budget.
But things are changing. What was once a little-understood industry, working diligently behind-the-scenes, has quickly become an area of interest and relevance to just about everybody, given the key role the sector has played during the COVID-19 outbreak.
Whilst regrettable that it has taken a pandemic to bring the health diagnostics sector into focus, it is a positive step forward for healthcare that the huge national and international scope of our sector is now rightly acknowledged.
Click the links below to hear from a range of clinicians, pathologists and public officials on the importance of diagnostics, and from our customers on their experience of Randox testing technologies.
Want to know more?
Contact us or read the latest news on Randox.
What We Do
Our History
Our Accreditations
Official statement from Randox on Covid-19 testing
03 April 2020
OFFICIAL STATEMENT FROM RANDOX
On the emergence of the Covid-19 threat Randox utilised their years of regulated diagnostic experience to quickly develop and robustly validate a test for the Covid-19 virus. Randox had significant confidence in this test and presented them to Public Health England (PHE) for evaluation. PHE were managing this validation process for each of England, Wales, Scotland and Northern Ireland.
The UK Government showed significant confidence in Randox’s capability and conducted full engagement and planning subject to PHE acceptance of the Randox test. When PHE acceptance was granted, the Randox part in the national plan had been prepared and was quickly initiated.
We understand that the national plan for the testing of key workers is exactly that, a national plan, inclusive of Northern Ireland. Initially relatively small numbers of tests were sent to the areas of significant national threat in London.
The planning for the national distribution of test kits is being managed by the various relevant statutory agencies however Randox has made the case that tests should be made available locally. Following that engagement, tests have now been made directly available within Northern Ireland and Randox will continue to support Northern Ireland within the UK national plan.
Randox have acted with speed and initiative throughout this crisis and will continue to ramp up our testing capability to support the national testing plan for key workers in Northern Ireland.
Every part of Randox’s business is focused on doing everything we can to support the Covid-19 testing programme, to both save lives and ensure the speediest possible return to a more normal society.
For more information please contact the Randox PR team by emailing randoxpr@randox.com
